» Articles » PMID: 24328731

Uncoupling Protein-2 Mediates DPP-4 Inhibitor-induced Restoration of Endothelial Function in Hypertension Through Reducing Oxidative Stress

Overview
Specialty Endocrinology
Date 2013 Dec 17
PMID 24328731
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Although uncoupling protein 2 (UCP2) negatively regulates intracellular reactive oxygen species (ROS) production and protects vascular function, its participation in vascular benefits of drugs used to treat cardiometabolic diseases is largely unknown. This study investigated whether UCP2 and associated oxidative stress reduction contribute to the improvement of endothelial function by a dipeptidyl peptidase-4 inhibitor, sitagliptin, in hypertension.

Results: Pharmacological inhibition of cyclooxygenase-2 (COX-2) but not COX-1 prevented endothelial dysfunction, and ROS scavengers reduced COX-2 mRNA and protein expression in spontaneously hypertensive rats (SHR) renal arteries. Angiotensin II (Ang II) evoked endothelium-dependent contractions (EDCs) in C57BL/6 and UCP2 knockout (UCP2KO) mouse aortae. Chronic sitagliptin administration attenuated EDCs in SHR arteries and Ang II-infused C57BL/6 mouse aortae and eliminated ROS overproduction in SHR arteries, which were reversed by glucagon-like peptide 1 receptor (GLP-1R) antagonist exendin 9-39, AMP-activated protein kinase (AMPK)α inhibitor compound C, and UCP2 inhibitor genipin. By contrast, sitagliptin unaffected EDCs in Ang II-infused UCP2KO mice. Sitagliptin increased AMPKα phosphorylation, upregulated UCP2, and downregulated COX-2 expression in arteries from SHR and Ang II-infused C57BL/6 mice. Importantly, exendin 9-39, compound C, and genipin reversed the inhibitory effect of GLP-1R agonist exendin-4 on Ang II-stimulated mitochondrial ROS rises in SHR endothelial cells. Moreover, exendin-4 improved the endothelial function of renal arteries from SHR and hypertensive patients.

Innovation: We elucidate for the first time that UCP2 serves as an important signal molecule in endothelial protection conferred by GLP-1-related agents. UCP2 could be a useful target in treating hypertension-related vascular events.

Conclusions: UCP2 inhibits oxidative stress and downregulates COX-2 expression through GLP-1/GLP-1R/AMPKα cascade.

Citing Articles

Regulatory Roles of Long Non-Coding RNAs in Arterial Stiffness and Hypertension: Insights from Two African American Studies.

Vargas J, Abbas M, Goodney G, Gaye A bioRxiv. 2024; .

PMID: 39372764 PMC: 11451656. DOI: 10.1101/2024.08.11.607492.


Emerging role and the signaling pathways of uncoupling protein 2 in kidney diseases.

Mao S Ren Fail. 2024; 46(2):2381604.

PMID: 39090967 PMC: 11299446. DOI: 10.1080/0886022X.2024.2381604.


Prostaglandin Transporter and Dipeptidyl Peptidase-4 as New Pharmacological Targets in the Prevention of Acute Kidney Injury in Diabetes: An In Vitro Study.

Gallego-Tamayo B, Santos-Aparicio A, Yago-Ibanez J, Munoz-Moreno L, Lucio-Cazana F, Fernandez-Martinez A Int J Mol Sci. 2024; 25(6).

PMID: 38542317 PMC: 10969968. DOI: 10.3390/ijms25063345.


Dipeptidyl peptidase-4 inhibitors versus sulfonylureas on the top of metformin in patients with diabetes and acute myocardial infarction.

Her A, Choi B, Rha S, Kim Y, Jeong M Cardiovasc Diagn Ther. 2024; 14(1):38-50.

PMID: 38434553 PMC: 10904300. DOI: 10.21037/cdt-23-349.


Perivascular Adipose Tissue Oxidative Stress in Obesity.

Man A, Zhou Y, Xia N, Li H Antioxidants (Basel). 2023; 12(8).

PMID: 37627590 PMC: 10451984. DOI: 10.3390/antiox12081595.


References
1.
Tian X, Wong W, Leung F, Zhang Y, Wang Y, Lee H . Oxidative stress-dependent cyclooxygenase-2-derived prostaglandin f(2α) impairs endothelial function in renovascular hypertensive rats. Antioxid Redox Signal. 2011; 16(4):363-73. PMC: 3584508. DOI: 10.1089/ars.2010.3874. View

2.
Mattiasson G, Sullivan P . The emerging functions of UCP2 in health, disease, and therapeutics. Antioxid Redox Signal. 2006; 8(1-2):1-38. DOI: 10.1089/ars.2006.8.1. View

3.
Garber A, Henry R, Ratner R, Garcia-Hernandez P, Rodriguez-Pattzi H, Olvera-Alvarez I . Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial. Lancet. 2008; 373(9662):473-81. DOI: 10.1016/S0140-6736(08)61246-5. View

4.
Xu M, Song P, Shirwany N, Liang B, Xing J, Viollet B . Impaired expression of uncoupling protein 2 causes defective postischemic angiogenesis in mice deficient in AMP-activated protein kinase α subunits. Arterioscler Thromb Vasc Biol. 2011; 31(8):1757-65. PMC: 3158995. DOI: 10.1161/ATVBAHA.111.227991. View

5.
Takaki A, Morikawa K, Tsutsui M, Murayama Y, Tekes E, Yamagishi H . Crucial role of nitric oxide synthases system in endothelium-dependent hyperpolarization in mice. J Exp Med. 2008; 205(9):2053-63. PMC: 2526200. DOI: 10.1084/jem.20080106. View